BCTXZ BriaCell Therapeutics Corp. - Warrant
NASDAQ · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Jun 9, 2026
$0.30
· of 52w range
· above low
· to high
$0.0752w low
$0.3052w high
Market Cap (MRQ)
$2M
EPS
$-62.19
your badges
52W Range
$0–$0
Analyst Rating
·
Price Target
·
P/E
·
ROE
-255.9%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
BCTXZ Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$0.30
Market Cap (MRQ)
$2M
EPS
$-62.19
ROE
-255.9%
52W Range
$0–$0
BCTXZ Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
EPS$-62.192022-07-31 → 2025-07-31
Free Cash Flow·2024-07-31 → 2024-07-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | BCTXZ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | 0.1 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | BCTXZ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -191.2%5Y avg ≈-82.9% | ≈-82.9% | · | · | |
| ROE | -255.9%5Y avg ≈1.7% | ≈1.7% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | BCTXZ | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 7.15Y avg ≈16.4 | ≈16.4 | · | · | |
| Quick Ratio | 4.55Y avg ≈15.0 | ≈15.0 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| R&D Expense | $21M | $27M | $15M | $8M | $2M | |
| SG&A Expense | $6M | $6M | $8M | $7M | $5M | |
| Operating Expenses | $27M | $33M | $23M | · | · | |
| Operating Income | $-27M | $-33M | $-23M | $-15M | $-7M | |
| Interest Expense | · | · | · | $979 | $78.6K | |
| Interest Income | $120.0K | $288.0K | $891.2K | $136.7K | $3.1K | |
| Other Non-op | $114.5K | $262.6K | $850.3K | $-12M | $-7M | |
| Pretax Income | $27M | $5M | $20M | $-27M | $-14M | |
| Net Income | $-26M | $-5M | $-20M | $-27M | $-14M | |
| EPS (Basic) | $-62.19 | $-43.68 | $-1.30 | $-1.73 | $-3.06 | |
| EPS (Diluted) | $-62.19 | $-43.68 | $-1.30 | $-1.73 | · | |
| Shares (Basic) | 423,114 | 109,699 | 15,619,676 | 15,494,091 | 4,519,579 | |
| Shares (Diluted) | 423,114 | 109,699 | 15,619,676 | 15,494,091 | · | |
| EBITDA | $-27M | $-33M | $-23M | $-15M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $862.1K | $21M | $41M | $57M | |
| Short-term Investments | $7M | · | · | · | · | |
| Receivables | · | · | $18.9K | $24.1K | $12.6K | |
| Prepaid Expense | $1M | $1M | $5M | $1M | $516.9K | |
| Current Assets | $20M | $4M | $27M | $42M | $58M | |
| PP&E (Net) | $296.8K | $388.2K | · | $2.5K | · | |
| PP&E (Gross) | · | $456.8K | · | · | · | |
| Intangibles | $184.5K | $199.8K | $215.1K | $230.3K | $245.6K | |
| Total Assets | $22M | $6M | $27M | $43M | $58M | |
| Current Liabilities | $4M | $7M | $2M | $941.1K | $556.8K | |
| Common Stock | $102M | $72M | $70M | $66M | $55M | |
| Paid-in Capital | · | · | $7M | · | · | |
| Retained Earnings | $-112M | $-85M | $-81M | $-60M | $-29M | |
| AOCI | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | |
| Stockholders' Equity | $17M | $-3M | $-4M | $10M | $28M | |
| Liabilities + Equity | $22M | $6M | $27M | $43M | $58M | |
| Shares Outstanding | 1,883,906 | 121,907 | 15,981,726 | 15,518,018 | 15,269,583 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| D&A | · | · | · | $15.3K | $15.3K | |
| Stock-based Comp | $776.9K | $2M | $2M | $3M | $2M | |
| Amort. of Intangibles | $15.3K | $15.3K | $15.3K | $15.3K | $15.3K | |
| Other Non-cash | · | · | · | $11M | · | |
| Operating Cash Flow | $-28M | $-24M | $-24M | $-12M | $-8M | |
| CapEx | · | $456.8K | · | · | · | |
| Investing Cash Flow | $-8M | $-681.8K | · | · | · | |
| Stock Issued | $45M | $4M | $4M | · | · | |
| Net Stock Activity | $45M | $4M | $4M | · | · | |
| Financing Cash Flow | $45M | $4M | $4M | $-4M | $65M | |
| Net Change in Cash | $10M | $-20M | $-20M | · | · | |
| Free Cash Flow | · | $-25M | · | · | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| ROA | -191.2% | -29.0% | -58.2% | -53.3% | · | |
| ROE | -255.9% | 107.5% | 419.9% | -264.6% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Current Ratio | 5.0 | 0.5 | 15.0 | 45.0 | · | |
| Quick Ratio | 4.5 | 0.1 | 11.8 | 43.6 | · | |
| Interest Coverage | · | · | · | -15616.9 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Book Value / Share | $9.20 | $-0.15 | $-0.24 | $0.67 | · | |
| Cash Flow / Share | $-66.58 | $-1.47 | $-1.52 | · | · | |
| Cash / Share | $5.57 | $0.05 | $1.33 | $2.64 | · | |
| EPS (TTM) | $-62.19 | $-43.68 | $-1.30 | $-1.73 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Net Income TTM | $-26M | $-5M | $-20M | $-27M | · |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $6M | $6M | $7M | $7M | $5M | $6M | $4M | $4M | $8M | $8M | $7M | $5M | $4M | $3M | $3M | $3M | |
| SG&A Expense | $2M | $1M | $2M | $1M | $2M | $1M | $1M | $1M | $2M | $2M | $2M | $3M | $2M | $1M | $2M | $2M | |
| Operating Expenses | $8M | $8M | $8M | $9M | $6M | $7M | $5M | $6M | $9M | $10M | $9M | $8M | $6M | $4M | $5M | · | |
| Operating Income | $-8M | $-8M | $-8M | $-9M | $-6M | $-7M | $-5M | $-6M | $-9M | $-10M | $-9M | $-8M | $-6M | $-4M | $-5M | $-5M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $0 | |
| Interest Income | $219.2K | $105.6K | $48.5K | $33.4K | $26.6K | $46.8K | $13.1K | $2 | $15.6K | $81.6K | $190.8K | $208.8K | $253.5K | $240.6K | $188.4K | $82.4K | |
| Other Non-op | $187.0K | $84.6K | $158.6K | $45.2K | $-9.8K | $67.4K | $11.7K | $-12.1K | $13.2K | $81.6K | $179.8K | $3M | $781.6K | $-7M | $4M | $5M | |
| Net Income | $-7M | $-7M | $-8M | $-8M | $-6M | $-6M | $-6M | $-1M | $2M | $-11M | $6M | $-2M | $-5M | $-12M | $-1M | $-450.4K | |
| EPS (Basic) | $-0.99 | $-2.58 | $-4.35 | $-4.57 | $-16.42 | $-23.31 | $-32.67 | $-35.03 | $1.61 | $-10.64 | $0.38 | $-0.14 | $-0.32 | $-0.77 | $-0.07 | · | |
| EPS (Diluted) | $-0.99 | $-2.58 | $-4.35 | $-4.57 | $-16.42 | $-23.31 | $-32.67 | $-34.15 | $1.61 | $-10.64 | $-0.50 | $-0.14 | $-0.32 | $-0.77 | $-0.07 | $-0.03 | |
| Shares (Basic) | 7,250,487 | 2,802,337 | 1,883,906 | · | 373,067 | 269,957 | 177,606 | · | 1,065,448 | 1,065,448 | 15,981,726 | · | 15,518,072 | 15,518,018 | 15,518,018 | · | |
| Shares (Diluted) | 7,250,487 | 2,802,337 | 1,883,906 | · | 373,067 | 269,957 | 177,606 | · | 1,065,448 | 1,065,448 | 16,674,891 | · | 15,518,072 | 15,518,018 | 15,518,018 | · | |
| EBITDA | $-8M | $-8M | $-8M | · | $-6M | $-7M | $-5M | · | $-9M | $-10M | $-9M | · | $-6M | $-4M | $-5M | · |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $30M | $3M | $10M | $12M | $5M | $6M | $862.1K | $935.7K | $6M | $14M | $21M | $28M | $34M | $37M | $41M | |
| Short-term Investments | $16M | · | $7M | $7M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Receivables | · | · | · | · | · | · | · | · | $15.2K | $30.1K | $21.4K | · | $14.9K | $8.9K | $29.7K | $24.1K | |
| Prepaid Expense | · | · | · | $1M | · | · | · | $1M | $5M | $5M | $5M | $5M | $1M | $429.4K | $742.1K | $1M | |
| Current Assets | $25M | $32M | $11M | $20M | $15M | $7M | $8M | $4M | $6M | $12M | $18M | $27M | $30M | $34M | $38M | $42M | |
| PP&E (Net) | $349.0K | $251.1K | $274.0K | $296.8K | $319.7K | $342.5K | $365.3K | $388.2K | · | · | · | · | · | · | · | · | |
| PP&E (Gross) | · | · | · | · | · | · | · | $456.8K | · | · | · | · | · | · | · | · | |
| Intangibles | · | · | $180.7K | $184.5K | $188.3K | $192.2K | $196.0K | $199.8K | $203.6K | $207.4K | $211.2K | $215.1K | $218.9K | $222.7K | $226.5K | $230.3K | |
| Total Assets | $27M | $34M | $13M | $22M | $17M | $9M | $10M | $6M | $6M | $12M | $19M | $27M | $30M | $34M | $38M | $43M | |
| Current Liabilities | $4M | $3M | $3M | $4M | $4M | $5M | $5M | $7M | $7M | $4M | $1M | $2M | $1M | $670.4K | $974.0K | $941.1K | |
| Common Stock | $117M | $117M | $102M | $102M | $94M | $85M | $82M | $72M | $70M | $70M | $70M | $70M | $66M | $66M | $66M | $66M | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | $8M | · | · | · | · | · | |
| Retained Earnings | $-134M | $-127M | $-120M | $-112M | $-104M | $-98M | $-91M | $-85M | $-84M | $-86M | $-75M | $-81M | $-78M | $-73M | $-61M | $-60M | |
| AOCI | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | $-138.7K | |
| Stockholders' Equity | $23M | $30M | $9M | $17M | $12M | $3M | $4M | $-3M | $-6M | $-8M | $3M | $-4M | $-6M | $-1M | $10M | $10M | |
| Liabilities + Equity | $27M | $34M | $13M | $22M | $17M | $9M | $10M | $6M | $6M | $12M | $19M | $27M | $30M | $34M | $38M | $43M | |
| Shares Outstanding | 7,250,487 | 7,250,487 | · | 1,883,906 | 6,558,092 | 2,946,940 | 36,183,161 | 121,907 | 15,981,726 | 15,981,726 | 15,981,726 | 15,981,726 | 15,518,318 | 15,518,018 | 15,518,018 | 15,518,018 |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | $26.7K | · | · | · | $3.8K | $3.8K | $3.8K | · | $3.8K | $3.8K | $3.8K | · | |
| Stock-based Comp | $432.2K | $285.9K | $294.7K | $0 | $224.8K | $285.1K | $267.0K | $377.9K | $392.2K | $500.2K | $533.8K | $533.8K | $281.2K | $266.8K | $1M | $877.9K | |
| Other Non-cash | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-4M | · | |
| Operating Cash Flow | $-7M | $-8M | $-8M | $-8M | $-7M | $-6M | $-7M | $-4M | $-5M | $-7M | $-8M | $-11M | $-5M | $-4M | $-4M | $-3M | |
| Investing Cash Flow | $-16M | $7M | $-75.0K | $-7M | $-105.0K | $-75.0K | $-75.0K | $-456.8K | · | · | · | · | · | · | · | · | |
| Stock Issued | $0 | · | · | $14M | $15M | $5M | $12M | · | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | · | · | · | · | · | $12M | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $0 | · | · | $14M | $15M | $5M | $12M | · | · | · | · | $4M | $1.6K | $0 | $-47.3K | $-159.8K | |
| Net Change in Cash | $-23M | $27M | $-8M | $-2M | $7M | $-778.6K | $5M | $-73.6K | $-5M | $-7M | $-8M | $-7M | · | · | · | · |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -32.5% | -33.6% | -69.8% | · | -52.8% | -58.3% | -40.0% | · | 9.6% | -48.7% | 21.0% | · | -32.9% | -69.6% | -5.8% | · | |
| ROE | -40.5% | -43.2% | -125.5% | · | -214.7% | 247.2% | -186.3% | · | -28.3% | 235.3% | 93.4% | · | 166.2% | 1855.7% | -21.4% | · |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.1 | 10.1 | 3.4 | · | 3.4 | 1.4 | 1.6 | · | 0.8 | 3.0 | 17.6 | · | 21.3 | 50.6 | 39.2 | · | |
| Quick Ratio | 6.4 | 9.4 | 3.1 | · | 2.9 | 1.0 | 1.2 | · | 0.1 | 1.6 | 13.1 | · | 20.4 | 50.0 | 38.5 | · |
Per Share
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.23 | $4.17 | · | · | $1.82 | $1.09 | $0.10 | · | $-0.39 | $-0.52 | $0.16 | · | $-0.38 | $-0.08 | $0.67 | · | |
| Cash Flow / Share | · | · | $-4.09 | · | · | · | $-0.26 | · | · | · | $-0.46 | · | · | · | · | · | |
| Cash / Share | $0.95 | $4.12 | · | · | $1.90 | $1.70 | $0.16 | · | $0.06 | $0.39 | $0.85 | · | $1.82 | $2.16 | $2.41 | · | |
| EPS (TTM) | $-12.49 | $-27.92 | $-48.65 | · | $-106.55 | $-88.52 | $-75.85 | · | $-9.67 | $-11.60 | $-1.73 | · | $-1.19 | $-1.52 | $-0.71 | · |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income TTM | $-31M | $-30M | $-29M | · | $-19M | $-12M | $-17M | · | $-6M | $-13M | $-13M | · | $-18M | $-23M | $-412.0K | · | |
| Market Cap | $832.4K | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/E | -0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P/B | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| P / Tangible Book | 0.0 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -10879.8% | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Net Income | $-26M | $-5M | $-20M | $-27M | $-14M |
| Diluted EPS | $-62.19 | $-43.68 | $-1.30 | $-1.73 | · |
| Metric | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Current Ratio | 5.0 | 0.5 | 15.0 | 45.0 | · |
| Quick Ratio | 4.5 | 0.1 | 11.8 | 43.6 | · |
| Metric | 2025-07-31 | 2024-07-31 | 2023-07-31 | 2022-07-31 | 2021-07-31 |
|---|---|---|---|---|---|
| Free Cash Flow | · | $-25M | · | · | · |
Institutional owners (13F) 5 filers · $56K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
5
Value held
$56K
New positions
3
Exited positions
2
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 3 (+3 vs prior Q) | 2 (+2 vs prior Q) | 0 (-1 vs prior Q) | 2 (0 vs prior Q) | -786K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| HEIGHTS CAPITAL MANAGEMENT, INC | $31,338 | 313,379 | 56.27% | Shares |
| SABBY MANAGEMENT, LLC | $11,464 | 120,802 | 20.59% | Shares |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11,452 | 114,522 | 20.56% | Shares |
| TWO SIGMA SECURITIES, LLC | $1,429 | 15,060 | 2.57% | Shares |
| HRT FINANCIAL LP | $6 | 67,935 | 0.01% | Shares |
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Jun 9, 2026